Search Results - Tracy Robson

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Dexamethasone promotes breast cancer stem cells in obese and not lean mice by Stephanie Annett, Orla Willis Fox, Damir Vareslija, Tracy Robson

    Published in Pharmacology Research & Perspectives (2022-04-01)
    Get full text
    Article


  2. 2

    Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives by Gillian Moore, Stephanie Annett, Lana McClements, Tracy Robson

    Published in Cells (2020-06-01)
    Get full text
    Article


  3. 3

    Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets by Yinshuang Chen, Yinshuang Chen, Weipeng Wang, Maria P. Morgan, Tracy Robson, Stephanie Annett

    Published in Frontiers in Endocrinology (2023-06-01)
    Get full text
    Article


  4. 4

    Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype by Chiara De Santi, Frances K. Nally, Remsha Afzal, Conor P. Duffy, Stephen Fitzsimons, Stephanie L. Annett, Tracy Robson, Jennifer K. Dowling, Sally-Ann Cryan, Claire E. McCoy

    Published in Molecular Therapy: Nucleic Acids (2022-09-01)
    Get full text
    Article


  5. 5

    The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway. by Anita Yakkundi, Lynn McCallum, Anthony O'Kane, Hayder Dyer, Jenny Worthington, Hayley D McKeen, Lana McClements, Christopher Elliott, Helen O McCarthy, David G Hirst, Tracy Robson

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  6. 6

    FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic Utility by Michael Chhor, Hao Chen, Djurdja Jerotić, Milorad Tešić, Valentina N. Nikolić, Milan Pavlović, Rada M. Vučić, Benjamin Rayner, Chris J. Watson, Mark Ledwidge, Kenneth McDonald, Tracy Robson, Kristine C. McGrath, Lana McClements

    Published in Biomolecules (2023-02-01)
    Get full text
    Article


  7. 7

    Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself. by Cian M McCrudden, Martin G O'Rourke, Kim E Cherry, Hiu-Fung Yuen, Declan O'Rourke, Muhammad Babur, Brian A Telfer, Huw D Thomas, Patrick Keane, Thiagarajan Nambirajan, Chris Hagan, Joe M O'Sullivan, Chris Shaw, Kaye J Williams, Nicola J Curtin, David G Hirst, Tracy Robson

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


Search Tools: